Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03042962 · ClinicalTrials.gov registry record
Brain Networks in Dystonia
A clinical trial of Spasmodic Dysphonia and Singer's Dystonia, sponsored by Massachusetts Eye and Ear Infirmary.
- Recruiting
- Registry status
- 141
- Enrollment target
- 1
- Study location
NCT03042962 is a study of Spasmodic Dysphonia and Singer's Dystonia that is actively recruiting participants, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 141 participants, above the 94-participant average among 7 other Spasmodic Dysphonia trials with a reported enrollment target (50% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03042962, a study of Spasmodic Dysphonia and Singer's Dystonia, is actively recruiting participants, sponsored by Massachusetts Eye and Ear Infirmary.
- RECRUITING
- Registry status
- 141 participants
- Enrollment target
- 1
- Study location
Study Summary
To date, there is only limited knowledge about the distinct neural abnormalities that lead to the development of different forms of focal dystonia. The goal of this study is to dissect the pathophysiological mechanisms underlying this clinical phenomenon using multi-level brain network analysis in patients with focal dystonia.
Conditions Studied
Interventions
- OTHER MRI
- PROCEDURE Blood draw
Study Locations (1)
Massachusetts
- Massachusetts Eye and Ear - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2015-08-01 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03042962
The ClinicalTrials.gov registry entry for NCT03042962 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 94-participant average among 7 other Spasmodic Dysphonia trials with a reported enrollment target (50% higher). The listed sponsor is Massachusetts Eye and Ear Infirmary, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Spasmodic Dysphonia appearing as the primary indexed condition, and to 2 interventions - of which MRI is the first listed.
NCT03042962 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03042962 about?
NCT03042962 is a clinical study titled "Brain Networks in Dystonia". To date, there is only limited knowledge about the distinct neural abnormalities that lead to the development of different forms of focal dystonia. The goal of this study is to dissect the pathophysiological mechanisms underlying this clinical phenomenon using multi-level brain network analysis in p...
What is the current status of trial NCT03042962?
This trial is currently recruiting. The enrollment target is 141 participants. The study started on 2015-08-01. Estimated completion is 2027-12-31.
What conditions does trial NCT03042962 study?
This clinical trial studies the following conditions: Spasmodic Dysphonia, Singer's Dystonia, Writer's Cramp, Musician's Focal Hand Dystonia, Craniofacial Dystonia.
What interventions are being tested in trial NCT03042962?
The interventions under investigation include: MRI (OTHER), Blood draw (PROCEDURE).
Who is sponsoring clinical trial NCT03042962?
This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03042962 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spasmodic Dysphonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Characterization of Clinical Phenotypes of Laryngeal Dystonia and Voice Tremor
RECRUITING
-
Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor
RECRUITING · Early Phase 1
-
Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor
RECRUITING · NA
-
Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia
ACTIVE NOT RECRUITING · Phase 1
-
Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia
COMPLETED
-
Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.